|
1
|
ACOG Committee on Obstetric Practice;
American College of Obstetricians and Gynecologists, . ACOG
practice bulletin. Diagnosis and management of preeclampsia and
eclampsia. Number 33, January 2002. Int J Gynaecol Obstet.
77:67–75. 2002.PubMed/NCBI
|
|
2
|
Duley L, Meher S and Abalos E: Management
of pre-eclampsia. BMJ. 332:463–468. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Poon LC and Nicolaides KH: Early
prediction of preeclampsia. Obstet Gynecol Int. 2014:2973972014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tal R: The role of hypoxia and
hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol
Reprod. 87:1342012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldman-Wohl D and Yagel S: Regulation of
trophoblast invasion: from normal implantation to pre-eclampsia.
Mol Cell Endocrinol. 187:233–238. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lam C, Lim KH and Karumanchi SA:
Circulating angiogenic factors in the pathogenesis and prediction
of preeclampsia. Hypertension. 46:1077–1085. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fruscalzo A, Schmitz R, Klockenbusch W,
Köhler G, Londero AP, Siwetz M and Huppertz B: Human placental
transthyretin in fetal growth restriction in combination with
preeclampsia and the HELLP syndrome. Histochem Cell Biol.
138:925–932. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y and Zhang Z: Does transthyretin
function as one of contributors for preeclampsia? Med Hypotheses.
76:8–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huppertz B, Kertschanska S, Demir AY,
Frank HG and Kaufmann P: Immunohistochemistry of matrix
metalloproteinases (MMP), their substrates, and their inhibitors
(TIMP) during trophoblast invasion in the human placenta. Cell
Tissue Res. 291:133–148. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hannan NJ, Paiva P, Dimitriadis E and
Salamonsen LA: Models for study of human embryo implantation:
choice of cell lines? Biol Reprod. 82:235–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Harris LK: Review: trophoblast-vascular
cell interactions in early pregnancy: how to remodel a vessel.
Placenta. 31(Suppl): S93–S98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hiden U, Bilban M, Knöfler M and Desoye G:
Kisspeptins and the placenta: regulation of trophoblast invasion.
Rev Endocr Metab Disord. 8:31–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pennington KA, Schlitt JM, Jackson DL,
Schulz LC and Schust DJ: Preeclampsia: multiple approaches for a
multifactorial disease. Dis Model Mech. 5:9–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaitu'u-Lino TJ, Ye L, Tuohey L,
Dimitriadis E, Bulmer J, Rogers P, Menkhorst E, Van Sinderen M,
Girling JE, Hannan N, et al: Corin, an enzyme with a putative role
in spiral artery remodeling, is up-regulated in late secretory
endometrium and first trimester decidua. Hum Reprod. 28:1172–1180.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren L, Liu YQ, Zhou WH and Zhang YZ:
Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and
invasion of human first-trimester decidual stromal cells. Hum
Reprod. 27:366–374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim YJ: Pathogenesis and promising
non-invasive markers for preeclampsia. Obstet Gynecol Sci. 56:2–7.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu X, Dai LI and Zhou R: Association
between preeclampsia and the CXC chemokine family (Review). Exp
Ther Med. 9:1572–1576. 2015.PubMed/NCBI
|
|
18
|
Gong LY, Zhang ZY, Zheng YH and Zhang JZ:
Study of a serum protein fingerprint diagnostic model in patients
with hypertensive disorder complicating pregnancy. Zhonghua Fu Chan
Ke Za Zhi. 42:822–825. 2007.(In Chinese). PubMed/NCBI
|
|
19
|
Liu C, Zhang N, Yu H, Chen Y, Liang Y,
Deng H and Zhang Z: Proteomic analysis of human serum for finding
pathogenic factors and potential biomarkers in preeclampsia.
Placenta. 32:168–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalkunte SS, Neubeck S, Norris WE, Cheng
SB, Kostadinov S, Vu Hoang D, Ahmed A, von Eggeling F, Shaikh Z,
Padbury J, et al: Transthyretin is dysregulated in preeclampsia,
and its native form prevents the onset of disease in a preclinical
mouse model. Am J Pathol. 183:1425–1436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu L, Chen Y, Liu C, Deng H, Zhang N,
Wang S and Zhang Z: Transthyretin as a novel candidate biomarker
for preeclampsia. Exp Ther Med. 7:1332–1336. 2014.PubMed/NCBI
|
|
22
|
Heissig B, Hattori K, Friedrich M, Rafii S
and Werb Z: Angiogenesis: vascular remodeling of the extracellular
matrix involves metalloproteinases. Curr Opin Hematol. 10:136–141.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Omran OM, Shokry M, Ismail H, Omar G and
Rezk M: Expression of matrix metalloproteinases 2 and 9 in human
trophoblasts of normal and preeclamptic placentas. Int J Health Sci
(Qassim) 5 (Suppl 1). 21–23. 2011.
|
|
24
|
Yang Y, Zhang J, Gong Y, Liu X, Bai Y, Xu
W and Zhou R: Increased expression of prostasin contributes to
early-onset severe preeclampsia through inhibiting trophoblast
invasion. J Perinatol. 35:16–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cockle JV, Gopichandran N, Walker JJ,
Levene MI and Orsi NM: Matrix metalloproteinases and their tissue
inhibitors in preterm perinatal complications. Reprod Sci.
14:629–645. 2007. View Article : Google Scholar : PubMed/NCBI
|
